How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
11 February, 2025•10 min
0
11 February, 2025•10 min
0
More in Business
Business
India takes an unapologetic stand at COP30
As talks harden, India drags finance and fairness into the conversation at the annual climate summit.
You may also like
Business
India takes an unapologetic stand at COP30
As talks harden, India drags finance and fairness into the conversation at the annual climate summit.
Business
Metro Brands’ premium shoes start to pinch
Revenue growth slows for the footwear company as consumption skids and rivals crowd the market.
Internet
Preparing to love China once again
India is warming up to the idea of doing business with China. Little is expected to change in the trade skew, but Chinese foreign direct investment will be a welcome boost.
